S0563657
BritishPharmacopoeia(BP)ReferenceStandard , 103-82-2
Synonym(s):
α-Toluic acid;α-Tolylic acid;Benzeneacetic acid;PAA;Phenylacetic acid
CAS NO.:103-82-2
Empirical Formula: C8H8O2
Molecular Weight: 136.15
MDL number: MFCD00004313
EINECS: 203-148-6
Update time: 2022-07-08
PRODUCT Properties
Melting point: | 76-78 °C(lit.) |
Boiling point: | 265 °C(lit.) |
Density | 1.081 g/mL at 25 °C(lit.) |
vapor density | ~4 (vs air) |
vapor pressure | 1 mm Hg ( 97 °C) |
FEMA | 2878 | PHENYLACETIC ACID |
refractive index | 1.5120 (estimate) |
Flash point: | 132°C |
storage temp. | Store at RT. |
solubility | DMF: 1 mg/ml; PBS (pH 7.2): 10 mg/ml |
pka | 4.28(at 18℃) |
color | Leaflets on distillation in vac; plates, tablets from pet ether |
Specific Gravity | 1.081 |
Odor | disagreeable odor of geranium |
PH | 3.7(1 mM solution);3.17(10 mM solution);2.66(100 mM solution) |
Odor Type | honey |
Water Solubility | 15 g/L (20 ºC) |
Merck | 14,7268 |
JECFA Number | 1007 |
BRN | 1099647 |
Dielectric constant | 3.0(20℃) |
Stability: | Stable. Incompatible with strong oxidizing agents. |
LogP | 0.811 at 25℃ |
Description and Uses
Phenylacetic Acid is used in the synthesis of Diclofenac (D436450) and its metabolite 4'-Hydroxydiclofenac (H825225), which is the principal human metabolite of Diclofenac.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H319 |
Precautionary statements | P305+P351+P338 |
Hazard Codes | Xi |
Risk Statements | 36/37/38 |
Safety Statements | 26-36-37/39 |
RIDADR | UN 3335 |
WGK Germany | 1 |
RTECS | AJ2430000 |
F | 13 |
TSCA | Yes |
HS Code | 29163400 |
Toxicity | LD50 orally in Rabbit: > 5000 mg/kg LD50 dermal Rabbit > 5000 mg/kg |